Login / Signup

Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?

Sebastian SchwindLara BischofMarius BillJuliane GrimmJule UssmannDonata BackhausDominic BrauerTung Pham ThanhMaximilian MerzGeorg-Nikolaus FrankeKlaus H MetzelerVladan VucinicMarco HerlingUwe PlatzbeckerMadlen Jentzsch
Published in: HemaSphere (2024)
Keyphrases
  • stem cell transplantation
  • high dose
  • acute myeloid leukemia
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • bone marrow
  • low dose
  • acute lymphoblastic leukemia